Hopital d'Instruction des Armees de Begin

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Prostate cancer2 trials

Phase

• Phase 32 trials

Status

• Completed1 trial
• Terminated1 trial

Lead sponsor

• Hinova Pharmaceuticals USA, Inc.1 trial
• Hoffmann-La Roche1 trial

Closed trials

• Terminated

  HC-1119 Versus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)

  NCT03850795· Phase 3· Hinova Pharmaceuticals USA, Inc.· Source

• Completed

  Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer

  NCT03072238· Phase 3· Hoffmann-La Roche· Source